The people at Chiesi Global Rare Diseases are motivated by a personal drive to help individuals impacted by rare diseases. We recognize that commitment. That’s why people are at the center of everything we do—from creating space for us to come together and grow, to therapies that can help support us and the ones we love, to making the world a healthier and safer planet. After all, we’re human, just like you.


Revolutionizing the lives of patients with rare diseases

As part of the broader Chiesi Group, we believe patients are at the heart of what we do. That’s why our journey (and commitment) begins with and centers on patients. We work in close partnership with patients, caregivers, medical, educational, and governmental entities to ensure regulatory, environmental, and pricing practices are beneficial to the patients we serve and every one of us.

We believe in passion, courage, teamwork, and innovation.

Our mission is to become a point of reference for all patients affected by rare diseases by 2025, to build a better future for patients, and to continue exploring new frontiers of treatment and care.


We are one big Global family

Growing and maintaining diversity in the workforce and ensuring equal opportunity and equal pay for equal work is a priority at Chiesi Global Rare Diseases. If we’re one big global family, then we need to make sure everyone has a seat at the table.


Like our patients, we believe our planet is one of a kind

Insert text here...

Certified B Corporation Certified B Corporation Certified B Corporation

Chiesi is the largest global pharmaceutical company to be awarded B Corporation Certification, a recognition of high social and environmental standards. It’s an achievement to be proud of, and yet it feels natural: caring for others is at the root of health science, and it has always been at the core of our work.

B Corporations are businesses that balance purpose with profit. With this status, we are legally required to consider the impact of our decisions on our employees, customers, suppliers, community, and the environment. This is a global movement of people using business as a force for good.

This means that we make uncommon decisions, which other companies might not take, and decisions that do not necessarily benefit the short-term income statement of the company.

While sustainability has always been important to Chiesi, today it is part of our strategic plan. This means we are committed to improving patient quality of life, protecting the planet and its inhabitants, supporting our communities, promoting the development of our people, and guaranteeing maximum transparency in the way we work. Read more about our Corporate Social Responsibility.

Actions we’ve taken to reduce our environmental footprint in 2020

  • 12% reduction of shipments by air
  • 9% reduction in water withdrawal compared to 2019
  • 6% reduction in waste production compared to 2019
  • 100% use of renewable energy at Italian sites
  • +900,000 kWh/y of renewable energy production produced in 2020

Learn More about Chiesi Global Rare Diseases

Find Treatments


Discover treatments that are helping to change the rare disease landscape.

Read More

Find Treatments


Discover innovative treatments that are helping to change the rare disease landscape.

Read More

See Pipeline


Explore novel therapies under development.

Read More


Explore rare disease therapies under development.

Read More

Be a Partner

a Partner

From understanding rare diseases to providing new products—together, we can do more.

Read More

Join the Family

the Family

Interested in a career at Chiesi Global Rare Diseases? We’d love to hear from you.

Read More